Biolife Solutions Stock Market Value
| BLFS Stock | USD 26.01 0.62 2.44% |
| Symbol | BioLife |
BioLife Solutions Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (1.11) | Revenue Per Share 3.222 | Quarterly Revenue Growth 0.297 | Return On Assets (0.06) |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioLife Solutions 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Solutions' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Solutions.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in BioLife Solutions on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding BioLife Solutions or generate 0.0% return on investment in BioLife Solutions over 720 days. BioLife Solutions is related to or competes with Teleflex Incorporated, Cooper Companies,, West Pharmaceutical, ICU Medical, AngioDynamics, AptarGroup, and Haemonetics. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene ther... More
BioLife Solutions Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Solutions' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Solutions upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.98 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 18.63 | |||
| Value At Risk | (5.60) | |||
| Potential Upside | 6.19 |
BioLife Solutions Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Solutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Solutions' standard deviation. In reality, there are many statistical measures that can use BioLife Solutions historical prices to predict the future BioLife Solutions' volatility.| Risk Adjusted Performance | 0.0184 | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0236 |
BioLife Solutions Backtested Returns
Currently, BioLife Solutions is not too volatile. BioLife Solutions secures Sharpe Ratio (or Efficiency) of 0.0192, which signifies that the company had a 0.0192% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for BioLife Solutions, which you can use to evaluate the volatility of the firm. Please confirm BioLife Solutions' Mean Deviation of 2.81, downside deviation of 3.98, and Risk Adjusted Performance of 0.0184 to double-check if the risk estimate we provide is consistent with the expected return of 0.0728%. BioLife Solutions has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.79, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioLife Solutions will likely underperform. BioLife Solutions right now shows a risk of 3.8%. Please confirm BioLife Solutions semi variance, and the relationship between the treynor ratio and daily balance of power , to decide if BioLife Solutions will be following its price patterns.
Auto-correlation | -0.62 |
Very good reverse predictability
BioLife Solutions has very good reverse predictability. Overlapping area represents the amount of predictability between BioLife Solutions time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Solutions price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current BioLife Solutions price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 12.81 |
BioLife Solutions lagged returns against current returns
Autocorrelation, which is BioLife Solutions stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioLife Solutions' stock expected returns. We can calculate the autocorrelation of BioLife Solutions returns to help us make a trade decision. For example, suppose you find that BioLife Solutions has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioLife Solutions regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioLife Solutions stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioLife Solutions stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioLife Solutions stock over time.
Current vs Lagged Prices |
| Timeline |
BioLife Solutions Lagged Returns
When evaluating BioLife Solutions' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioLife Solutions stock have on its future price. BioLife Solutions autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioLife Solutions autocorrelation shows the relationship between BioLife Solutions stock current value and its past values and can show if there is a momentum factor associated with investing in BioLife Solutions.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.